XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-based Compensation (Tables)
3 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of stock option activity

The summary of the Company’s stock option activity is as follows:

 

 

 

Number of Options

 

 

Weighted-Average Exercise Price

 

 

Weighted-Average Remaining Contractual Term

 

 

Aggregate Intrinsic Value

 

 

 

 

 

 

 

 

 

(In years)

 

 

(In thousands)

 

Outstanding at October 1, 2022

 

 

10,802,882

 

 

$

13.37

 

 

 

4.5

 

 

$

10,956

 

Exercised

 

 

(730,376

)

 

 

11.10

 

 

 

 

 

 

 

Forfeited

 

 

(20,943

)

 

 

15.19

 

 

 

 

 

 

 

Outstanding at December 31, 2022

 

 

10,051,563

 

 

$

13.53

 

 

 

4.2

 

 

$

33,834

 

At December 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

Options exercisable

 

 

10,039,063

 

 

$

13.54

 

 

 

4.2

 

 

$

33,762

 

Options vested and expected to vest

 

 

10,051,332

 

 

$

13.53

 

 

 

4.2

 

 

$

33,833

 

Schedule of restricted stock unit activity The summary of the Company’s RSU activity is as follows

 

 

Number of Units

 

 

Weighted-Average Grant Date Fair Value

 

 

Aggregate Intrinsic Value

 

 

 

 

 

 

 

 

 

(In thousands)

 

Outstanding at October 1, 2022

 

 

8,308,177

 

 

$

19.25

 

 

$

115,484

 

Granted

 

 

4,658,164

 

 

 

17.40

 

 

 

 

Released

 

 

(992,867

)

 

 

15.97

 

 

 

 

Forfeited

 

 

(182,718

)

 

 

18.95

 

 

 

 

Outstanding at December 31, 2022

 

 

11,790,756

 

 

$

18.80

 

 

$

199,264

 

At December 31, 2022

 

 

 

 

 

 

 

 

 

Units expected to vest

 

 

9,943,485

 

 

$

18.66

 

 

$

168,045

 

Schedule of performance stock units activity

 

 

 

Number of Units

 

 

Weighted-Average Grant Date Fair Value

 

 

Aggregate Intrinsic Value

 

 

 

 

 

 

 

 

 

(In thousands)

 

Outstanding at October 1, 2022

 

 

398,077

 

 

$

26.96

 

 

$

5,533

 

Granted

 

 

249,370

 

 

 

17.54

 

 

 

 

Vested

 

 

(263,158

)

 

 

26.26

 

 

 

 

Outstanding at December 31, 2022

 

 

384,289

 

 

$

21.33

 

 

$

6,494

 

 

Schedule of stock-based compensation expense

Total stock-based compensation expense by functional category was as follows:

 

 

 

Three Months Ended

 

 

 

December 31,
2022

 

 

January 1,
2022

 

(In thousands)

 

 

 

 

 

 

Cost of revenue

 

$

570

 

 

$

328

 

Research and development

 

 

9,151

 

 

 

6,738

 

Sales and marketing

 

 

4,113

 

 

 

3,647

 

General and administrative

 

 

6,361

 

 

 

6,746

 

Total stock-based compensation expense

 

$

20,195

 

 

$

17,459